FSD Pharma Inc. (HUGE) Company Long-Term Loans and Borrowings

FSD Pharma - graphic logo of issuer HUGE

FSD Pharma Inc. (HUGE) focuses on developing high-precision drugs to combat severe inflammation and neuronal degeneration. The market price on the GURU.Markets platform, where long-term debt stands at 0.00, as confirmed by this chart, is complemented by the stability of a tight-knit circle of leading neurobiologists. Business development relies on a strategic alliance with biotech centers to identify new therapeutic approaches in the field of neurology.

HUGE FSD Pharma: Company Long-Term Debts in the range 07/04/2022 - 08/15/2024

HUGE (FSD Pharma): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price fsdpharma.com|HUGE - Price Target Chart
- market capitalization data:
Market Value FSD Pharma|HUGE - Total Company Value
- book capitalization data:
Accounting Value per Share FSD Pharma|HUGE - Book Capitalization|Market Capitalization to Book Value Ratio fsdpharma.com|HUGE - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio FSD Pharma Inc.|HUGE - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio FSD Pharma, Inc.|HUGE - Company Aggregate Debts|Debts to Book Value FSD Pharma|HUGE - Company Long-Term Liabilities|Company Short-Term Debts FSD Pharma
Fundamental valuation:HUGE - fsdpharma.com
Manufactured products of fsdpharma.com

The indicator aggregates all confirmed credit obligations with maturities exceeding twelve months. The calculation is based on verified reporting data, excluding subjective estimates. The long-term debt dynamics for FSD Pharma Inc. (HUGE) reflect the actual volume of raised capital. This metric is critical for FSD Pharma Inc. during a shift in R&D focus, as it demonstrates the startup's financial stability during the transition to clinical trials for neurological drugs.

Who FSD Pharma Inc. competes with

jazzpharma.com - Company Long-Term Debts|Company Long-Term Debt Cytokinetics, Incorporated (CYTK)|PTCT: Company Long-Term Loans and Borrowings|SRRK (Scholar Rock Corp) - Company Long-Term Debt|Centessa Corp (CNTA) - Company Long-Term Liabilities|DYN (Dyne Therapeutics, Inc.) - Company Long-Term Debts|Company Long-Term Debts edgewisetx.com (EWTX)|Rapport Therapeutics (RAPP) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings ALMS (Alumis Inc)|ZVRA - Company Long-Term Debt|Company Long-Term Indebtedness Contineum Corp CTNM|LRMR (Larimar Therapeutics) - Company Long-Term Debts|Capricor Therapeutics (CAPR) - Long-Term Debt|TRDA: Company Long-Term Liabilities|PTHS (Channel Therapeutics Inc.) - Company Long-Term Debts|MNOV - Company Long-Term Debt|Company Long-Term Loans and Borrowings SER|BioXcel Therapeutics - Company Long-Term Debt|Long-Term Debt PMN (promisneurosciences.com)|Company Long-Term Debt Apimeds Pharmaceuticals US APUS|AEON Biopharma Inc. - Company Long-Term Debt|NLSP (NLS Pharma) - Company Long-Term Debt|BNOX - Long-Term Debt|Company Long-Term Debts RETA (Reata Pharmaceuticals)